1.525 USD
-0.03 (-1.61%)
ChartMill assigns a Buy % Consensus number of 83% to SLS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.97. This target is 357.05% above the current price.
SLS was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SLS.
In the previous month the buy percentage consensus was at a similar level.
SLS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-16 | Maxim Group | Maintains | Buy -> Buy |
| 2023-11-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2022-11-15 | Alliance Global Partners | Maintains | Buy |
| 2022-06-28 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-07-21 | Cantor Fitzgerald | Initiate | Overweight |
SELLAS LIFE SCIENCES GROUP I / SLS FAQ
What is the price target for SLS stock?
7 analysts have analysed SLS and the average price target is 6.97 USD. This implies a price increase of 357.05% is expected in the next year compared to the current price of 1.525.
What is the consensus rating for SELLAS LIFE SCIENCES GROUP I (SLS) stock?
The consensus rating for SELLAS LIFE SCIENCES GROUP I (SLS) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.